P S I Construction Co Inc is categorized under Pharmaceutical Manufacturing Plant Construction in , and active since 2004.
P S I Construction Co Inc was established in 2004, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Pharmaceutical Manufacturing Plant Construction business, which does work in the B2B market, and is classified as a Pharmaceutical Manufacturing Plant Construction, under code number 236220 by the NAICS.
If you are seeking more information, feel free to contact Jaime Soler at the company’s single location by writing to Road 796 Km 0 3 Guasabara St Ro, , 00726 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | P S I Construction Co Inc |
| Contact Person: | Jaime Soler |
| Address: | Road 796 Km 0 3 Guasabara St Ro, , 00726 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Pharmaceutical Manufacturing Plant Construction |
| SIC Code: | 1541 |
| NAICS Code: | 236220 |
| Share This Business: |
P S I Construction Co Inc was started in 2004 to provide professional Pharmaceutical Manufacturing Plant Construction under the SIC code 1541 and NAICS code 236220. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Jaime Soler for inquiries that concern P S I Construction Co Inc by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of P S I Construction Co Inc can be found at the coordinates as well as the street address Road 796 Km 0 3 Guasabara St Ro in , 00726.
For its online presence, you may visit P S I Construction Co Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.